The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor

Abstract Cross talk between cancer cells and the immune system is determinant for cancer progression. Emerging evidence demonstrates that GC characteristics such as metastasis, treatment resistance, and disease recurrence are associated with a tumor subpopulation called gastric cancer stem cells (GC...

Full description

Bibliographic Details
Main Authors: Jared Becerril-Rico, Eduardo Alvarado-Ortiz, Mariel E. Toledo-Guzmán, Rosana Pelayo, Elizabeth Ortiz-Sánchez
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-021-02562-9
_version_ 1819124299163762688
author Jared Becerril-Rico
Eduardo Alvarado-Ortiz
Mariel E. Toledo-Guzmán
Rosana Pelayo
Elizabeth Ortiz-Sánchez
author_facet Jared Becerril-Rico
Eduardo Alvarado-Ortiz
Mariel E. Toledo-Guzmán
Rosana Pelayo
Elizabeth Ortiz-Sánchez
author_sort Jared Becerril-Rico
collection DOAJ
description Abstract Cross talk between cancer cells and the immune system is determinant for cancer progression. Emerging evidence demonstrates that GC characteristics such as metastasis, treatment resistance, and disease recurrence are associated with a tumor subpopulation called gastric cancer stem cells (GCSCs). However, the specific interaction between GCSCs and the immune microenvironment is still under investigation. Although immune evasion has been well described for cancer stem cells (CSCs), recent studies show that GCSCs can also regulate the immune system and even benefit from it. This review will provide an overview of bidirectional interactions between CSCs and immune cells in GC, compiling relevant data about how CSCs can induce leukocyte reprogramming, resulting in pro-tumoral immune cells that orchestrate promotion of metastasis, chemoresistance, tumorigenicity, and even increase in number of cancer cells with stem properties. Some immune cells studied are tumor-associated macrophages (TAMs), neutrophils, Th17 and T regulatory (Treg) cells, mesenchymal stem cells (MSCs), and cancer-associated fibroblasts (CAFs), as well as the signaling pathways involved in these pro-tumoral activities. Conversely, although there are cytotoxic leukocytes that can potentially eliminate GCSCs, we describe mechanisms for immune evasion in GCSCs and their clinical implications. Furthermore, we describe current available immunotherapy targeting GCSC-related markers as possible treatment for GC, discussing how the CSC-modified immune microenvironment can mitigate or inactivate these immunotherapies, limiting their effectiveness. Finally, we summarize key concepts and relevant evidence to understand the cross talk between GCSCs and the immune microenvironment as an important process for effective design of therapies against GCSCs that improve the outcome of patients with GC.
first_indexed 2024-12-22T07:22:02Z
format Article
id doaj.art-45adf53ee98c4d489ef62bdd114ecc1e
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-22T07:22:02Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-45adf53ee98c4d489ef62bdd114ecc1e2022-12-21T18:34:14ZengBMCStem Cell Research & Therapy1757-65122021-09-0112111410.1186/s13287-021-02562-9The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factorJared Becerril-Rico0Eduardo Alvarado-Ortiz1Mariel E. Toledo-Guzmán2Rosana Pelayo3Elizabeth Ortiz-Sánchez4Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Secretaría de SaludPrograma de Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de MéxicoSubdirección de Investigación Básica, Instituto Nacional de Cancerología, Secretaría de SaludCentro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Delegación PueblaSubdirección de Investigación Básica, Instituto Nacional de Cancerología, Secretaría de SaludAbstract Cross talk between cancer cells and the immune system is determinant for cancer progression. Emerging evidence demonstrates that GC characteristics such as metastasis, treatment resistance, and disease recurrence are associated with a tumor subpopulation called gastric cancer stem cells (GCSCs). However, the specific interaction between GCSCs and the immune microenvironment is still under investigation. Although immune evasion has been well described for cancer stem cells (CSCs), recent studies show that GCSCs can also regulate the immune system and even benefit from it. This review will provide an overview of bidirectional interactions between CSCs and immune cells in GC, compiling relevant data about how CSCs can induce leukocyte reprogramming, resulting in pro-tumoral immune cells that orchestrate promotion of metastasis, chemoresistance, tumorigenicity, and even increase in number of cancer cells with stem properties. Some immune cells studied are tumor-associated macrophages (TAMs), neutrophils, Th17 and T regulatory (Treg) cells, mesenchymal stem cells (MSCs), and cancer-associated fibroblasts (CAFs), as well as the signaling pathways involved in these pro-tumoral activities. Conversely, although there are cytotoxic leukocytes that can potentially eliminate GCSCs, we describe mechanisms for immune evasion in GCSCs and their clinical implications. Furthermore, we describe current available immunotherapy targeting GCSC-related markers as possible treatment for GC, discussing how the CSC-modified immune microenvironment can mitigate or inactivate these immunotherapies, limiting their effectiveness. Finally, we summarize key concepts and relevant evidence to understand the cross talk between GCSCs and the immune microenvironment as an important process for effective design of therapies against GCSCs that improve the outcome of patients with GC.https://doi.org/10.1186/s13287-021-02562-9Cancer stem cellsGastric cancerImmunoregulationImmunotherapyCancer microenvironmentCell reprogramming
spellingShingle Jared Becerril-Rico
Eduardo Alvarado-Ortiz
Mariel E. Toledo-Guzmán
Rosana Pelayo
Elizabeth Ortiz-Sánchez
The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
Stem Cell Research & Therapy
Cancer stem cells
Gastric cancer
Immunoregulation
Immunotherapy
Cancer microenvironment
Cell reprogramming
title The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
title_full The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
title_fullStr The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
title_full_unstemmed The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
title_short The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor
title_sort cross talk between gastric cancer stem cells and the immune microenvironment a tumor promoting factor
topic Cancer stem cells
Gastric cancer
Immunoregulation
Immunotherapy
Cancer microenvironment
Cell reprogramming
url https://doi.org/10.1186/s13287-021-02562-9
work_keys_str_mv AT jaredbecerrilrico thecrosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT eduardoalvaradoortiz thecrosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT marieletoledoguzman thecrosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT rosanapelayo thecrosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT elizabethortizsanchez thecrosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT jaredbecerrilrico crosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT eduardoalvaradoortiz crosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT marieletoledoguzman crosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT rosanapelayo crosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor
AT elizabethortizsanchez crosstalkbetweengastriccancerstemcellsandtheimmunemicroenvironmentatumorpromotingfactor